Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Peer Support for Achieving Independence in Diabetes [NA]
This entry notes a completed clinical trial on peer support interventions to help people with Type 2 diabetes achieve independence. No pharm…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy [Phase 4]
Phase 4 clinical trial update evaluating insulin pump therapy to improve glycemic control in Malaysian patients with Type 2 Diabetes Mellitu…
-
CLINICAL_TRIALS research · 2017-04-13Clinical Trial Update: Feasibility Study of Digital Photography and Group Discussion for People With Diabetes [NA]
This ClinicalTrials.gov entry reports a terminated feasibility study evaluating digital photography and group discussion for adults with Typ…
-
CLINICAL_TRIALS research · 2017-04-12Clinical Trial Update: Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics [NA]
A completed clinical trial evaluating a brief alcohol intervention to reduce at-risk drinking among individuals with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating diastolic dysfunction in patients with type 2 diabetes mellitus has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial evaluating linagliptin for vascular inflammation in patients with type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
A completed clinical trial assessing whether Type 2 diabetes mellitus acts as a catalyst for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Smoking Cessation Intervention for Diabetic Patients [NA]
This update reports a completed clinical trial testing a smoking cessation intervention in patients with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease
The study explored retinal neurodegeneration in type 2 diabetes as a potential biomarker for Alzheimer's disease. The trial status is comple…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome [Phase 2]
A Phase 2 study evaluating the safety and tolerability of PBI-4050 in patients with type 2 diabetes and metabolic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin [Phase 4]
A Phase 4 clinical trial update reporting completion and posted results for dapagliflozin on 24-hour blood glucose in adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: The VALIDATE-D Study [NA]
Completed results update for the VALIDATE-D trial in type 2 diabetes and obesity; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin [Phase 4]
A Phase 4 trial evaluated adding vildagliptin to metformin in patients with type 2 diabetes mellitus inadequately controlled on metformin; r…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Confronting Unequal Eye Care in Pennsylvania [NA]
A completed clinical trial update from Wills Eye on unequal access to eye care in Pennsylvania, involving patients with diabetic retinopathy…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes [NA]
The trial update reports results from a study examining whether CPAP therapy improves glucose control in patients with obstructive sleep apn…
-
CLINICAL_TRIALS research · 2017-04-10Clinical Trial Update: Circulating Extracellular Vesicles Released by Human Islets of Langerhans
A clinical trial assessing circulating extracellular vesicles released by human islets of Langerhans in participants with Type 1 or Type 2 d…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) [Phase 3]
Phase 3 trial evaluating ertugliflozin with sitagliptin for Type 2 Diabetes Mellitus in patients not adequately controlled on diet and exerc…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog [Phase 4]
A Phase 4 study evaluating lixisenatide in type 2 diabetes patients who failed other GLP-1 therapies has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Changing the Healthcare Delivery Model [NA]
Completed clinical trial led by George Washington University evaluating a healthcare delivery model for Type 2 diabetes; results were posted…
-
FDA approval · 2017-04-05FDA Approved: RIOMET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for RIOMET (metformin hydrochloride) from Sun Pharmaceutical Industries.
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Glipizide and Metformin Hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of glipizide and metformin hydrochloride (Glipizide and Met…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) [Phase 4]
This entry reports the completion of a Phase 4 trial evaluating pioglitazone for nonalcoholic steatohepatitis (NASH) and related fatty liver…
-
FDA approval · 2017-04-05FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HCL, a fixed-dose combination tablet, by Heritage Pharmaceuticals (Avet)…
-
FDA approval · 2017-04-04FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of glipizide and metformin hydrochloride (GLIPIZIDE AND MET…